ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 409

Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lung Inflammation Evaluated With High Resolution Computed Tomography Scan Is Correlated To Rheumatoid Arthritis Disease Activity

Jorge Rojas-Serrano1, Renzo Perez-Dorame2, Heidegger Mateos-Toledo2 and Mayra Mejia3, 1Interstitial Lung Diseases Unit, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico, 2Intertitial Lung Disease Unit, Instituto Nacional de Enfermedades Respiratorias, Mexico, Mexico, 3Interstitial Lung Disease Unit, Instituto Nacional de Enfermedades Respiratorias Dr. Ismael Cosío Villegas. México DF., México, D.F., Mexico

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Lung Disease and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects I: Comorbidities in Rheumatoid Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: To describe the association between rheumatoid arthritis disease activity (RA) and interstitial lung damage (inflammation and fibrosis), in a cohort of rheumatoid arthritis-associated interstitial lung disease (RA-ILD) patients. 

Methods: A retrospective study of RA patients with interstitial lung disease (restrictive pattern in lung function tests and evidence of interstitial lung disease in high resolution computed tomography (HRCT)). Patients had a complete evaluation to exclude other causes of pulmonary disease. RA disease activity was measured with the CDAI index. Interstitial lung inflammation and fibrosis were determined by Kazerooni scale. We compared Kazerooni ground-glass score with the nearest CDAI score to HRCT date scan. In 18 patients, a bronchoalveolar lavage (BAL) cell profile (lymphocytes cell count, neutrophils cell count and macrophages cell count) was available and was correlated with the nearest CDAI index. In nine patients, we compared the first ground-glass score with a second one after treatment with DMARs and corticosteroids. Spearman’s rank correlation coefficient was used to evaluate the association between RA disease activity with the Kazerooni ground-glass and fibrosis scores, and with the BAL cell profiles. 

Results: Thirty-four patients were included. A positive correlation between CDAI and ground-glass scores was found (rs= 0.3767 (P < 0.028). Fibrosis and CDAI scores were not associated (rs= -0.0747, p < 0.6745). In the 18 patients with BAL lavage, lymphocytes cell count correlated strongly with the CDAI index (rs= 0.58, p < 0.011). After treatment, a tendency to lowering in ground-glass score was observed (median [IQR]): (2.33 [2-3] vs. 2 [1.33-2.16]), p<0.056, along with lowering in CDAI score (27 [8-43] vs. 9 [5-12]), p<0.063.

Conclusion: there is a correlation between RA disease activity and ground glass in HRCT in RA-ILD patients. Lymphocytic BAL in RA seems to correlate with disease activity. Ground glass may respond to treatment.


Disclosure:

J. Rojas-Serrano,
None;

R. Perez-Dorame,
None;

H. Mateos-Toledo,
None;

M. Mejia,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rheumatoid-arthritis-associated-interstitial-lung-disease-lung-inflammation-evaluated-with-high-resolution-computed-tomography-scan-is-correlated-to-rheumatoid-arthritis-disease-activity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology